New Flowserve digital positioner features predictive diagnostics

Published: 30-Mar-2010
Manufacturing

Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family

Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family. This smart positioner features the advanced diagnostics capability of Flowserve ValveSight for facilities using Foundation Fieldbus protocol.

'Next-generation facilities use Foundation Fieldbus technology because it allows easy integration of field instruments into a central control system,' said Ken Beatty, Director of Advanced Product Development, Flowserve Flow Control Division. 'The Logix 3400MD helps plant operators run their control processes more efficiently by identifying issues before they become costly failures.'

The Logix 3400MD uses Flowserve ValveSight technology to monitor the status of the valve, actuator and positioner, and the health of the entire control loop. Proprietary models provide predictive diagnostics, which give advanced warning of future equipment or process problems.

The Flowserve Logix 3400MD features the same proven, state-of-the-art technology as the Logix 3200MD to provide superior performance and reliability. It is certified by all major digital control system suppliers, the FDT Group and the Fieldbus Foundation.

For more information about the Logix 3400MD digital positioner, please call a Flowserve sales representative at +1 800 225-6989.
See more

You may also like

Training & Education

Flowserve opens training centre in Italy

Read more
Adds to global network of Learning Resource Centres

Trending Articles

  1. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  2. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  3. Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Executive with over 20 years of management experience to lead pharmaceutical packaging and delivery systems company
  4. Abzena and Mabqi announce strategic partnership to offer integrated discovery through development solution This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    The cross-pollination effect: how shared learnings bear fruit for drug sponsors This article explores how contract development and manufacturing organisations leverage the cross-pollination of knowledge to help drug sponsors overcome critical challenges in pharmaceutical development

You may also like

Training & Education

Flowserve opens training centre in Italy

Adds to global network of Learning Resource Centres
Manufacturing

Flowserve swing check valves help increase reliability in chemical applications

Redesigned Flowserve Noble Alloy swing check valve offers corrosion resistance and high reliability
Manufacturing

Pioneering Peptide-Builder debuts at UEA

Vapourtec kept it local with the first ever installation of their pioneering production Peptide-Builder system taking place at the University of East Anglia (UEA) in Norwich
Manufacturing

Moderna invests $140m to onshore drug product manufacturing and complete US end-to-end mRNA network

Moderna is expanding its Norwood, Massachusetts site to bring drug product manufacturing in-house, creating hundreds of biomanufacturing jobs and establishing full domestic, end-to-end production for its mRNA vaccines and therapeutics by 2027
Manufacturing

GEA to showcase Rockwell Automation-Compatible GEA kytero 2000 Single-Use Separator at Automation Fair 2025

As a gold-level OEM member of the Rockwell PartnerNetwork™, GEA is strengthening its collaboration with Rockwell by offering full compatibility between the kytero® 2000 and Rockwell’s latest hardware and software suite
Manufacturing

SU Puresonic ultrasonic sensor ensures precise hygienic flow measurement

Innovative design meets the highest standards in food, pharma, and water treatment
Manufacturing

Breaking down silos and building in seamless scale

A Q&A with Kindeva's Tommy Schornak on the Bridgeton facility, Annex 1 compliance and scaling sterile injectable production
Subscribe now